These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33588438)

  • 21. Cyathea gigantea (Cyatheaceae) as an antimicrobial agent against multidrug resistant organisms.
    Nath K; Talukdar AD; Bhattacharya MK; Bhowmik D; Chetri S; Choudhury D; Mitra A; Choudhury NA
    BMC Complement Altern Med; 2019 Oct; 19(1):279. PubMed ID: 31640666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends and correlation between antibacterial consumption and carbapenem resistance in gram-negative bacteria in a tertiary hospital in China from 2012 to 2019.
    Liang C; Zhang X; Zhou L; Meng G; Zhong L; Peng P
    BMC Infect Dis; 2021 May; 21(1):444. PubMed ID: 34001022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on the antibiotic resistance crisis.
    Rossolini GM; Arena F; Pecile P; Pollini S
    Curr Opin Pharmacol; 2014 Oct; 18():56-60. PubMed ID: 25254623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance.
    Lee SY; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radical scavenging and antibacterial activity of caffemides against gram positive, gram negative and clinical drug resistance bacteria.
    Misra K; Maity HS; Nag A; Sonawane A
    Bioorg Med Chem Lett; 2016 Dec; 26(24):5943-5946. PubMed ID: 27865704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial and antibiotic-resistance modifying activity of the extracts and compounds from Nauclea pobeguinii against Gram-negative multi-drug resistant phenotypes.
    Seukep JA; Sandjo LP; Ngadjui BT; Kuete V
    BMC Complement Altern Med; 2016 Jul; 16():193. PubMed ID: 27386848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibacterial drug resistance in Latin America: consequences for infectious disease control].
    Casellas JM
    Rev Panam Salud Publica; 2011 Dec; 30(6):519-28. PubMed ID: 22358396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The antibacterial activity of cinnamon oil on the selected gram-positive and gram-negative bacteria].
    Urbaniak A; GÅ‚owacka A; Kowalczyk E; Lysakowska M; Sienkiewicz M
    Med Dosw Mikrobiol; 2014; 66(2):131-41. PubMed ID: 25369660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New antibacterial agents for treating infections caused by multi-drug resistant Gram-negative bacteria.
    O'Neill AJ
    Expert Opin Investig Drugs; 2008 Mar; 17(3):297-302. PubMed ID: 18321229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk factors, etiology, and drug resistance of infection after plastic surgery, and corresponding measures.
    Wang G; Zhang S
    Minerva Chir; 2017 Dec; 72(6):499-504. PubMed ID: 28233479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Battle against Vancomycin-Resistant Bacteria: Recent Developments in Chemical Strategies.
    Dhanda G; Sarkar P; Samaddar S; Haldar J
    J Med Chem; 2019 Apr; 62(7):3184-3205. PubMed ID: 30404451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of pathogenic bacteria and drug resistance in neonatal purulent meningitis].
    Zhu M; Hu Q; Mai J; Lin Z
    Zhonghua Er Ke Za Zhi; 2015 Jan; 53(1):51-6. PubMed ID: 25748405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-resistant gram-negative uropathogens: A review.
    Khoshnood S; Heidary M; Mirnejad R; Bahramian A; Sedighi M; Mirzaei H
    Biomed Pharmacother; 2017 Oct; 94():982-994. PubMed ID: 28810536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites.
    Fulkerson E; Valle CJ; Wise B; Walsh M; Preston C; Di Cesare PE
    J Bone Joint Surg Am; 2006 Jun; 88(6):1231-7. PubMed ID: 16757755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shifting trends in bacterial keratitis in Toronto: an 11-year review.
    Lichtinger A; Yeung SN; Kim P; Amiran MD; Iovieno A; Elbaz U; Ku JY; Wolff R; Rootman DS; Slomovic AR
    Ophthalmology; 2012 Sep; 119(9):1785-90. PubMed ID: 22627118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic resistance: how it arises, the current position and strategies for the future.
    Perry C; Hall C
    Nurs Times; 2009 Sep 15-21; 105(36):20-3. PubMed ID: 19835196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotic resistance patterns of Gram-negative and Gram-positive strains isolated from inpatients with nosocomial infections in a tertiary hospital in Beijing, China from 2011 to 2014.
    Zhu X; Tong A; Wang D; Sun H; Chen L; Dong M
    J Chemother; 2017 Oct; 29(5):317-320. PubMed ID: 27347770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survey of the susceptibility of urinary isolates to antibacterial agents in 2003.
    Ishikawa K; Hayakawa S; Miyakawa S; Kusaka M; Shiroki R; Hoshinaga K
    J Infect Chemother; 2005 Feb; 11(1):44-7. PubMed ID: 15729488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.